The advantages and disadvantages of utilizing Fetal Bovine Serum (FBS) and animal-derived components have been discussed at the conference "Advancements in Animal-Free Research and Translational Medicine". PELOBiotech's first conference was fully booked and took place at the IZB in Munich/Planegg on June 27, 2024.
Leading voices in the field such as Prof. Dr. Gerhard Gstraunthaler, emer., University of Innsbruck, Austria, Dr. Lothar Steeb, CEO/CSO PELOBiotech, discussed ethical considerations regarding FBS and alternatives like human Platelet Lysate (hPL), serum-free, animal component-free media, xeno-free options, and defined media and the latest developments in translational medicine.
First used as a cell culture supplement FBS promotes cell growth, and its use has continued largely because it is effective for a wide range of cell types. FBS provides a rich source of growth factors, hormones, and proteins, making it a versatile and comparatively inexpensive option for cell culture.
